Friday, December 20, 2013
US pharmaceutical group Amgen is to acquire Onyx Pharmaceuticals in a $10.4 billion (€7.8bn) deal that gives Amgen access to a rapidly expanding cance(...)
AstraZeneca chief financial officer Simon Lowth will leave the UK’s second-biggest drugmaker at the end of October to join natural-gas producer BG Gro(...)
India's top court has dismissed Swiss company Novartis's attempt to win patent protection for its newly-updated cancer drug Glivec.
Browse by Publication Date